Cover Image

First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome

B. Palterer, G. Vitiello, D. Cammelli
  • B. Palterer
    Experimental and Clinical Medicine Dept., University of Florence, Florence, Italy
  • D. Cammelli
    Rheumatology Section/Immunoallergology Unit, AOU-Careggi, Florence, Italy


Inflammatory myopathies as para-neoplastic phenomena were first described by Sterz in 1916. Recently, myositis specific autoantibodies were described in cancer-associated myositis. Anti-transcription intermediary factor 1 gamma (anti-TIF1γ) antibodies have been found in both young adults affected by juvenile dermatomyositis and in elderly patients with cancer-associated myositis. In this regard, we report herein the first case of anti-TIF1γ dermatomyositis secondary to a myelodysplastic syndrome.


Myelodisplastic syndrome; Myositis specific autoantibodies;Anti-TIF1γ; Dermatomyositis.

Full Text:

Submitted: 2016-09-10 23:25:40
Published: 2017-08-03 15:30:44
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:


Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Copyright (c) 2017 B. Palterer, G. Vitiello, D. Cammelli

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185     •     Privacy